About: Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV734, a small molecule G protein biased ligand of the MOR, which has completed phase I studies for the treatment of moderate-to-severe acute and chronic pain; and TRV045, a novel S1P modulator for managing chronic pain. Trevena, Inc. was incorporated in 2007 and is headquartered in Chesterbrook, Pennsylvania.
Sector: Healthcare
Industry: Biotechnology
Latest price: $0.00 (-60.00%)
Status: deslistada — removed_from_provider. Este ativo não é mais negociado; são exibidos dados históricos.
TRVN NASDAQ Trevena Inc
Trevena Inc share price
Atividade de preço de TRVN
Último preço
Variação (24h)
USD
Volume
-
Volume (média 4 sem.)
-
Fechamento anterior
N/D
Último negócio
TRVN price performance
quote.marketSignals